Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu
Trial record 32 of 78 for:    vismodegib

Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Vismodegib Before Surgery in Pancreatic Cancer (NEOPACHI-001)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01713218
Recruitment Status : Unknown
Verified October 2012 by Jean-Luc Van Laethem, Erasme University Hospital.
Recruitment status was:  Not yet recruiting
First Posted : October 24, 2012
Last Update Posted : October 24, 2012
Roche Pharma AG
Information provided by (Responsible Party):
Jean-Luc Van Laethem, Erasme University Hospital

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : June 2014
Estimated Study Completion Date : December 2016